Godil Jamila, Rapp Katrina, Smith Spencer, Ryu Won Hyung A, Yoo Jung U
Department of Orthopaedics and Rehabilitation, Oregon Health & Science University, Portland, OR, USA.
Department of Neurological Surgery, Oregon Health & Science University, Portland, OR, USA.
Global Spine J. 2025 Mar;15(2):877-883. doi: 10.1177/21925682231215679. Epub 2023 Nov 16.
Retrospective Cohort Study.
This study aimed to examine the effect of state legislation on prescribing behavior after a commonly performed spinal procedure, posterior lumbar interbody fusion (PLIF).
Two cohorts of patients from the Pearl Diver Database were created based on patients who underwent PLIF surgery in 2014-15 and 2018-19. We compared opioid prescription rates and morphine-milli-equivalent (MME) between states with and without prescription legislation.
We analyzed 50 958 PLIF patients from 2014-15 and 46 751 patients from 2018-19. Among them, 38 states passed opioid prescription laws in 2016-2017, while 12 states did not. The percentage of patients receiving opioid prescriptions within 365 days post-surgery remained similar in both time periods (49% in 2014-15 and 48% in 2018-2019). This trend was consistent across states with and without prescription legislation (50% vs 48% in 2014-2015, and similar in 2018-19). Opioid prescription quantity significantly decreased in all states between 2014-15 and 2018-19. In states with legislation, average MME dropped from 9198 ± 21 002 to 4932 ± 13 213 (46.4% decrease), and in states without legislation, it decreased from 9175 ± 21 032 to 4994 ± 11 687 (45.6% decrease). However, these differences were not statistically significant ( = .7985).
From 2014 to 2018, there was a significant decrease in the number of opioids prescribed after PLIF. However, this decrease occurred irrespective of state legislation on prescribing practices being passed. We believe the reduction in opioids prescribed was due to increased awareness surrounding the dangers of opioids among physicians.
回顾性队列研究。
本研究旨在探讨州立法对常见脊柱手术后即后路腰椎椎间融合术(PLIF)处方行为的影响。
根据2014 - 2015年和2018 - 2019年接受PLIF手术的患者,从珍珠潜水员数据库中创建了两组患者队列。我们比较了有和没有处方立法的州之间的阿片类药物处方率和吗啡毫克当量(MME)。
我们分析了2014 - 2015年的50958例PLIF患者和2018 - 2019年的46751例患者。其中,38个州在2016 - 2017年通过了阿片类药物处方法,而12个州没有。术后365天内接受阿片类药物处方的患者百分比在两个时间段内保持相似(2014 - 2015年为49%,2018 - 2019年为48%)。这一趋势在有和没有处方立法的州都是一致的(2014 - 2015年分别为50%和48%,2018 - 2019年相似)。2014 - 2015年至2018 - 2019年期间,所有州的阿片类药物处方量均显著下降。在有立法的州,平均MME从9198±21002降至4932±13213(下降46.4%),在没有立法的州,从9175±21032降至4994±11687(下降45.6%)。然而,这些差异无统计学意义(P = 0.7985)。
2014年至2018年,PLIF术后开具的阿片类药物数量显著减少。然而,这一下降与州立法是否通过处方规定无关。我们认为阿片类药物处方量的减少是由于医生对阿片类药物危险性的认识提高。